MedTrace Logo

Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation

NCT02734355 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2017-03-22

Study results available
· View outcomes & findings →

Summary

The objective of the study was to estimate the efficacy of telmisartan and amlodipine combination on the restoration of left atrial mechanical function after atrial fibrillation catheter ablation.

Conditions

Interventions

DRUG

Telmisartan 80 mg and amlodipine 5 mg

DRUG

Placebo (for telmisartan and amlodipine)

Sugar pill manufactured to mimic telmisartan 80 mg and amlodipine 5 mg tablet

Sponsors & Collaborators

  • Research Institute for Complex Problems of Cardiovascular Diseases, Russia

    lead OTHER

Principal Investigators

  • Yevgeny V Grigoriev, M.D., Ph.D. · Research Institute for Complex Problems of Cardiovascular Diseases

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-01-31
Completion
2016-02-29

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02734355 on ClinicalTrials.gov